Here are relevant reports on : nuclear-medicine-market
-
Fluorometer Market by Light source (Lamps, LEDs, Diode Lasers, and Lasers), Application (Chemistry/Biochemistry, Medicine & Others), and End User (Hospitals, Pharmaceutical and Biotechnology Firms & CROs, Others) - Global Forecast to 2023
The global Fluorometer market is expected to reach USD 668.2 million by 2023 from USD 521.1 million in 2018, growing at a CAGR of 5.1%. Increasing incidence of cancer, advancement in cancer diagnostics, technological advancement in fluorometry are some of the major factors driving the growth of the global fluorometer market. These driving factors consequence to the rapid adoption of these new devices, thus propelling the market growth.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Precision Medicine Software Market by Delivery Mode (On-Premise & Cloud-Based), End User (Healthcare Providers, Research Centers & Government Institutes, Pharmaceutical & Biotechnology Companies), Application, and Region - Global Forecast to 2024
The precision medicine software market is projected to reach USD 2.0 billion by 2024, at a CAGR of 11.5%. Factors such as the rising government funding in precision medicine initiatives, partnerships among pharmaceutical and software companies, the entry of new players & VC funding, and growth in the number of cancer patients are driving the growth of the precision medicine software market. However, the high cost of deployment, issues related to the secure storage of large volumes of sequenced data, lack of reimbursement for precision medicine-based treatments, and the dearth of skilled IT professionals in healthcare are expected to restrain market growth to a certain extent in the coming years. Syapse, Inc. (US), 2bPrecise LLC (Israel), Foundation Medicine, Inc. (US), Fabric Genomics (US), SOPHiA GENETICS SA (Switzerland), PierianDx, Inc. (US), N-of-One, Inc. (US), Human Longevity, Inc. (US), Translational Software, Inc. (US), Sunquest Information Systems Inc. (US), Gene42, Inc. (Canada), LifeOmic Health, LLC (US), NantHealth, Inc. (US), Tempus Labs, Inc. (US), Flatiron Health, Inc. (US), IBM Watson Group (US), and Koninklijke Philips N.V. (Netherlands)
- Published: March 2019
- Price: $ 4950
- TOC Available:
-
Electroceuticals Market / Bioelectric Medicine Market by Product (Cardiac Pacemakers, ICD, Cochlear Implant, Neuromodulation (Deep Brain Stimulation)), Type (Implantable, Non-Invasive), Application (Arrhythmia, Heart Failure, Epilepsy) & Region - Global Forecast to 2029
The global electroceuticals market, valued at US$21.9 billion in 2023, stood at US$23.9 billion in 2024 and is projected to advance at a resilient CAGR of 7.0% from 2024 to 2029, culminating in a forecasted valuation of US$33.6 billion by the end of the period. Growth of the overall market is largely driven by the increasing incidence of cardiovascular, hearing loss and neurological disorders, increasing research in these field of disorders, and rising awareness regarding electroceuticals devices.
- Published: March 2024
- Price: $ 4950
- TOC Available:
-
Sports Medicine Market by Product [Repair (Fracture & Ligament), Reconstruction, Implant, Prosthetic, Arthroscopy , Physiotherapy , Orthobiologics, Brace), Application (Knee, Shoulder, Ankle, Hip, Spine), End-User - Global Forecast to 2029
The global sports medicine market, valued at US$6.41 billion in 2023, stood at US$6.79 billion in 2024 and is projected to advance at a resilient CAGR of 6.8% from 2024 to 2029, culminating in a forecasted valuation of US$9.45 billion by the end of the period. Major drivers include increased cases of sports injury, the rise in participation in sports events, increased expenditure on research and development, and increased funding and research activities.
- Published: September 2024
- Price: $ 4950
- TOC Available:
-
Mice Model Market by Model Type (Inbred, Outbred, Hybrid), Service (Breeding, Rederivation), Application (Personalized Medicine), Technology (Microinjection, CRISPR/Cas9), Therapeutic Area (Oncology, Neurology), End User (CROs) - Global Forecast to 2030
The global mice model market, valued at US$1.53 billion in 2024, stood at US$1.70 billion in 2025 and is projected to advance at a resilient CAGR of 10.0% from 2025 to 2030, culminating in a forecasted valuation of US$2.74 billion by the end of the period. The growth of this market is driven by several factors, such as rising adoption of mice models in preclinical studies due to genetic & physiological versatility; the increasing demand for mouse clinical trials; the rising demand for personalized medicine in oncology; and advancements in genetic engineering.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Capnography Devices Market by Product [Capnograhs (Stand-Alone, Hand-Held, Multi-Parameter) & Disposables], Application (Procedural Sedation, Critical Care, Emergency Medicine, Pain Management) & End User (Hospital, Ambulatory) - Global Forecasts to 2019
Emerging markets such as China, India, and Brazil are offering high growth opportunities for companies engaged in the development and marketing of capnographs. Huge patient’s population base, rising incidences of diseases and increasing aging population, and Government initiatives to develop their healthcare facilities are the key factors propelling demand for capnographs in these emerging nations.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Latin American Bioinformatics Market by Sector (Agriculture, Molecular Medicine, Research & Animal), Segment (Sequencing Platforms, Knowledge Management Tools & Data Analysis Services) & Application (Genomics, Proteomics & Drug Design) - Forecasts to 2017
The Latin American bioinformatics market was valued at $242 million in 2012 and is poised to reach $627 million by 2017, at a CAGR of 22%. The Latin American bioinformatics market displays lucrative growth potential. It is propelled by the rising number of training and development programs on usage of bioinformatics tools, which leads to an increase in the use of bioinformatics tools by industrial and academic bioinformaticians in life sciences research. In addition, the market is further driven by the high concentration of bioinformatics research institutes in Latin America that aim to facilitate the use of bioinformatics in life sciences research. However, the dearth of skilled personnel and facilities to ensure the proper use of bioinformatics products and services and the dearth of advanced and innovative bioinformatics tools and algorithms are limiting the growth of the bioinformatics market in Latin America.
- Published: March 2014
- Price: $ 4950
- TOC Available:
-
Transradial Access Market by Product (Catheters, Guidewires, Sheath and Sheath Introducers), Application (Administration of Medicine and Administration of fluids), End User (Hospitals, Clinics & Ambulatory Centres) - Global Forecast 2022
The transradial access devices market is projected to reach USD 2.18 Billion by 2022 from USD 1.52 Billion in 2017, at a CAGR of 7.5%. The prominent players include Becton, Dickinson and Company (US) and Terumo Corporation (Japan), Teleflex Incorporated (US), Smiths Group Plc (UK), Edward Lifesciences Corporation (US), Medtronic (Ireland), Merit Medical System, Inc. (US), Boston Scientific (US), NIPRO Medical Corporation (US), AngioDynamics (US), Ameco Medical Industries (Egypt), and OSCOR Inc. (US).
- Published: March 2018
- Price: $ 4950
- TOC Available:
-
NLP in Healthcare & Life Sciences Market by NLP Technique (OCR, NER, Sentiment Analysis), Application (Genomics & Precision Medicine, Patient Care & Engagement, Clinical Operations & Decision Support, Biomedical Research) - Global Forecast to 2030
The NLP in healthcare & life sciences market is expanding rapidly, with a projected market size anticipated to rise from about USD 5.18 billion in 2025 to USD 16.01 billion by 2030, featuring a CAGR of 25.3%. The major players in the NLP in healthcare & life sciences market include Microsoft (US), Google (US), IQVIA (US), Oracle (US), IBM (US), Lexalytics (US), Averbis (Germany), Emtelligent (Canada), Gnani.ai (India), and Deep 6 AI (US).
- Published: May 2025
- Price: $ 7150
- TOC Available:
-
Digital Pharmacy Market by Drug (Rx, OTC), Product (Medicine, Personal Care, Vitamins & Supplements, Diabetes, CVD, Oncology), Platform (Apps, Websites), Business Model (Captive, Franchise, Aggregator), Geographic (Urban, Rural) - Global Forecast to 2027
The global digital pharmacy market growth is primed to transition from USD 96.5 billion in 2022 to USD 211.9 billion by 2027, showcasing a strong CAGR of 17.0%. Key drivers include the rising consumer preference for online medicine purchases, especially during and after the COVID-19 pandemic, market consolidations, and the aging population.
- Published: June 2022
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
